Brian Robb Douglass's most recent trade in Repligen Corp. was a trade of 221 Common Stock done at an average price of $125.0 . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Repligen Corp | Brian Robb Douglass | CHIEF PRODUCT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 124.97 per share. | 02 Mar 2026 | 221 | 8,319 (0%) | 0% | 125.0 | 27,618 | Common Stock |
| Repligen Corp | Brian Robb Douglass | CHIEF PRODUCT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 2,288 | 8,540 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp | Brian Robb Douglass | CHIEF PRODUCT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 2,143 | 2,143 | - | - | Stock Option (Right to Buy) |